NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · IEX Real-Time Price · USD
2.330
0.00 (0.00%)
At close: Jul 19, 2024, 4:00 PM
2.390
+0.060 (2.58%)
Pre-market: Jul 22, 2024, 7:00 AM EDT
NRx Pharmaceuticals Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for NRx Pharmaceuticals stock has a target of 43, which predicts an increase of 1,745.49% from the current stock price of 2.33.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jun 7, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for NRXP is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $50 → $43 | Strong Buy | Maintains | $50 → $43 | +1,745.49% | Jun 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +758.37% | May 25, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +758.37% | Feb 2, 2023 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +1,616.74% | Nov 9, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $20 | Strong Buy | Initiates | $20 | +758.37% | Jun 30, 2022 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.27
from -4.00
EPS Next Year
-1.89
from -3.27
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | n/a | n/a | 52.5M |
| Avg | n/a | n/a | 51.0M |
| Low | n/a | n/a | 49.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -2.54 | -1.94 | 1.05 |
| Avg | -3.27 | -1.89 | 1.02 |
| Low | -3.92 | -1.81 | 0.98 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.